Position in BBIO
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$8,000,567
+$3,861,694 QoQ
Shares Held
107,419
+98.5% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1
of 30 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $205,108,253 across 117 Biotechnology names. BBIO ranks #3 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
101,908 | $10,865,430 | |
| 2 | MRNA |
Moderna, Inc.
|
139,861 | $9,794,465 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
This page
|
107,419 | $8,000,567 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
22,923 | $5,610,862 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
67,374 | $5,342,084 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
573,581 | $4,800,872 | |
| 7 | UPB |
Upstream Bio, Inc.
|
693,555 | $4,799,400 | |
| 8 | NRIX |
Nurix Therapeutics, Inc.
|
192,434 | $4,668,448 |
All Filings in BBIO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,000,567 | 107,419 | Shares | Sole | 2026-07-14 | |
| 2025-12-31 | $4,138,873 | 54,110 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $723,576 | 13,931 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $9,112,361 | 211,032 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $712,891 | 25,980 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $338,083 | 13,279 | Shares | Sole | 2024-11-15 | |
| 2023-12-31 | $1,057,371 | 26,192 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $374,559 | 14,204 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $200,956 | 20,217 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||